“At the 20th Congress of the European Hematology Association (EHA), Dr Andrew Davies, Honorary Senior Lecturer and Consultant in Medical Oncology at the University of Southampton, UK, talks about the opportunities and challenges of applying our increasing understanding of the biology of lymphoma in the development of better and more personalized treatments.”